{
    "abstract": "Cardiovascular conditions (eg, cardiac and coronary conditions, hypertensive disorders of pregnancy, and cardiomyopathies) were the leading cause of maternal mortality between 2017 and 2019. The United States has the highest maternal mortality rate of any high-income nation, disproportionately impacting those who identify as non-Hispanic Black or Hispanic. Novel clinical approaches to the detection and diagnosis of cardiovascular conditions are therefore imperative. Emerging research is demonstrating that machine learning (ML) is a promising tool for detecting patients at increased risk for hypertensive disorders during pregnancy. However, additional studies are required to determine how integrating ML and big data, such as electronic health records (EHRs), can improve the identification of obstetric patients at higher risk of cardiovascular conditions.\nThis study aimed to evaluate the capability and timing of a proprietary ML algorithm, Healthy Outcomes for all Pregnancy Experiences-Cardiovascular-Risk Assessment Technology (HOPE-CAT), to detect maternal-related cardiovascular conditions and outcomes.\nRetrospective data from the EHRs of a large health care system were investigated by HOPE-CAT in a virtual server environment. Deidentification of EHR data and standardization enabled HOPE-CAT to analyze data without pre-existing biases. The ML algorithm assessed risk factors selected by clinical experts in cardio-obstetrics, and the algorithm was iteratively trained using relevant literature and current standards of risk identification. After refinement of the algorithm's learned risk factors, risk profiles were generated for every patient including a designation of standard versus high risk. The profiles were individually paired with clinical outcomes pertaining to cardiovascular pregnancy conditions and complications, wherein a delta was calculated between the date of the risk profile and the actual diagnosis or intervention in the EHR.\nIn total, 604 pregnancies resulting in birth had records or diagnoses that could be compared against the risk profile; the majority of patients identified as Black (n=482, 79.8%) and aged between 21 and 34 years (n=509, 84.4%). Preeclampsia (n=547, 90.6%) was the most common condition, followed by thromboembolism (n=16, 2.7%) and acute kidney disease or failure (n=13, 2.2%). The average delta was 56.8 (SD 69.7) days between the identification of risk factors by HOPE-CAT and the first date of diagnosis or intervention of a related condition reported in the EHR. HOPE-CAT showed the strongest performance in early risk detection of myocardial infarction at a delta of 65.7 (SD 81.4) days.\nThis study provides additional evidence to support ML in obstetrical patients to enhance the early detection of cardiovascular conditions during pregnancy. ML can synthesize multiday patient presentations to enhance provider decision-making and potentially reduce maternal health disparities.",
    "authors": [
        {
            "affiliation": "MedStar Health Research Institute, Hyattesville, MD, United States.\nGeorgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC, DC, United States.",
            "firstname": "Nawar",
            "initials": "N",
            "lastname": "Shara"
        },
        {
            "affiliation": "School of Nursing, Georgetown University, Washington, DC, United States.",
            "firstname": "Roxanne",
            "initials": "R",
            "lastname": "Mirabal-Beltran"
        },
        {
            "affiliation": "Invaryant Inc, Roswell, GA, United States.",
            "firstname": "Bethany",
            "initials": "B",
            "lastname": "Talmadge"
        },
        {
            "affiliation": "MedStar Health Research Institute, Hyattesville, MD, United States.",
            "firstname": "Noor",
            "initials": "N",
            "lastname": "Falah"
        },
        {
            "affiliation": "MedStar Health Research Institute, Hyattesville, MD, United States.",
            "firstname": "Maryam",
            "initials": "M",
            "lastname": "Ahmad"
        },
        {
            "affiliation": "Invaryant Inc, Roswell, GA, United States.",
            "firstname": "Ramon",
            "initials": "R",
            "lastname": "Dempers"
        },
        {
            "affiliation": "Invaryant Inc, Roswell, GA, United States.",
            "firstname": "Samantha",
            "initials": "S",
            "lastname": "Crovatt"
        },
        {
            "affiliation": "Invaryant Inc, Roswell, GA, United States.",
            "firstname": "Steven",
            "initials": "S",
            "lastname": "Eisenberg"
        },
        {
            "affiliation": "School of Nursing, Georgetown University, Washington, DC, United States.",
            "firstname": "Kelley",
            "initials": "K",
            "lastname": "Anderson"
        }
    ],
    "conclusions": null,
    "copyrights": "\u00a9Nawar Shara, Roxanne Mirabal-Beltran, Bethany Talmadge, Noor Falah, Maryam Ahmad, Ramon Dempers, Samantha Crovatt, Steven Eisenberg, Kelley Anderson. Originally published in JMIR Cardio (https://cardio.jmir.org), 22.04.2024.",
    "doi": "10.2196/53091\n10.1097/AOG.0000000000001556\n10.1016/j.jacc.2022.08.769\n10.1016/j.ajogmf.2020.100250\n10.3233/THC-209018\n10.2196/34932\n10.1002/uog.27478\n10.1136/bmjopen-2023-074705\n10.1161/CIRCRESAHA.116.307547\n10.1161/JAHA.120.017832?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub0pubmed\n10.1161/JAHA.120.017832\n10.1089/jwh.2020.8868\n10.1007/s11606-017-4289-2\n10.1093/jamia/ocaa072\n10.1161/CIR.0000000000000772?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub0pubmed\n10.1161/CIR.0000000000000772\n10.1016/j.jacc.2020.08.071\n10.1111/1471-0528.15607\n10.1016/j.eclinm.2020.100701\n10.1016/j.artmed.2019.101785\n10.2196/35465\n10.1080/10641955.2024.2312165\n10.1080/10641955.2024.2312165\n10.1080/14779072.2023.2223978\n10.1126/sciadv.abk1942?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub0pubmed\n10.1126/sciadv.abk1942\n10.1007/s40471-017-0130-z\n10.1016/j.ajog.2015.05.008",
    "journal": "JMIR cardio",
    "keywords": [
        "EHR",
        "HOPE-CAT",
        "cardiovascular",
        "cardiovascular condition",
        "decision-making",
        "electronic health record",
        "health disparities",
        "health disparity",
        "kidney failure",
        "machine learning",
        "maternal",
        "obstetrics",
        "preeclampsia",
        "pregnancy",
        "pregnant",
        "retrospective study",
        "technology",
        "thromboembolism",
        "virtual server",
        "woman",
        "women"
    ],
    "methods": null,
    "publication_date": "2024-04-23",
    "pubmed_id": "38648629\n27500333\n36302590\n33451620\n32364150\n35142637\n37698356\n37696628\n27081110\n33322915\n24804357\n33237831\n29374357\n32324855\n32362133\n33121718\n30628159\n33490929\n32143792\n35297766\n38385188\n37300317\n36260666\n31223556\n25979616",
    "results": "In total, 604 pregnancies resulting in birth had records or diagnoses that could be compared against the risk profile; the majority of patients identified as Black (n=482, 79.8%) and aged between 21 and 34 years (n=509, 84.4%). Preeclampsia (n=547, 90.6%) was the most common condition, followed by thromboembolism (n=16, 2.7%) and acute kidney disease or failure (n=13, 2.2%). The average delta was 56.8 (SD 69.7) days between the identification of risk factors by HOPE-CAT and the first date of diagnosis or intervention of a related condition reported in the EHR. HOPE-CAT showed the strongest performance in early risk detection of myocardial infarction at a delta of 65.7 (SD 81.4) days.",
    "title": "Use of Machine Learning for Early Detection of Maternal Cardiovascular Conditions: Retrospective Study Using Electronic Health Record Data.",
    "xml": "<Element 'PubmedArticle' at 0x788504e602c0>"
}